Discovery Data Pipeline
Acellera Therapeutics differential approach to drug discovery is reflected by a uniquely large pipeline of target data with high biological and disease validation.
We offer target-specific collaborations on these or any other targets you may be interested in.
We offer target-specific collaborations on these or any other targets you may be interested in.
Pipeline
Target
Target Class
Approach
Therapeutic Area
Druggability Assessment
Hit Identification
Hit-to-Lead
Orthosteric
Breast cancer
Done
Done
Done
In progress
In progress
In progress
Allosteric
Inflammatory disease
Done
Done
Done
In progress
In progress
In progress
Orthosteric
Immuno-oncology
Done
Done
Done
-
-
-
Orthosteric
Solid tumors
Done
Done
Done
-
-
-
Orthosteric
Colorectal Cancer
Done
Done
Done
-
-
-
Orthosteric
Infectious diseases
Done
Done
Done
-
-
-
Allosteric
Longevity
Done
Done
Done
-
-
-
Allosteric
Renal cell carcinoma
Done
Done
Done
-
-
-
Allosteric
Acute myeloid leukaemia
Done
Done
Done
-
-
-
Allosteric
Multiple sclerosis
Done
Done
Done
-
-
-
Inhibitor
Autoimmune diseases
Done
In progress
In progress
-
-
-
Get in touch to know more details.